Management of Complex Diabetic Patient with Oral Discomfort and Multiple Foot Ulcers
Continue the current comprehensive wound care and offloading strategy for the diabetic foot ulcers, maintain aggressive glycemic control with insulin adjustments, and monitor the oral candidiasis resolution while ensuring the patient remains on appropriate cardiovascular risk reduction therapy including aspirin and a statin. 1
Diabetic Foot Ulcer Management Priority
The patient has multiple active diabetic foot ulcers (left plantar hallux, right dorsum, left heel) with peripheral arterial disease, which places him at extremely high risk for amputation and mortality. Patients with diabetes, foot ulceration, and PAD have approximately 50% 5-year mortality rate, making this the most critical issue requiring immediate attention. 2
Wound Care and Offloading
- For the plantar forefoot ulcer (left hallux), the patient requires a non-removable knee-high offloading device as the gold standard treatment to promote healing of neuropathic plantar ulcers without severe ischemia or uncontrolled infection. 1
- The current wound care regimen with gentian violet and silver alginate/foam dressings should continue with the established schedule (weekly for hallux, PRN for right dorsum, M/W/F for left heel). 1
- If the ulcers fail to show >50% wound area reduction after 6 weeks of optimal management, consider vascular imaging and revascularization regardless of bedside test results. 1
- Pressure-relief devices and off-loading measures to bed and chair must be maintained rigorously. 1
Vascular Assessment and Management
- The patient is already on aspirin and cilostazol, which is appropriate, but ensure a statin is prescribed for aggressive cardiovascular risk management in this patient with ischemic foot ulcers. 1
- Given the PAD diagnosis, monitor for signs that would trigger urgent vascular imaging: ankle pressure <50 mmHg, ABI <0.5, or non-healing ulcers despite 6 weeks of optimal care. 1
- If infection develops in the setting of PAD, this constitutes an emergency requiring urgent treatment as these patients are at particularly high risk for major limb amputation. 1
- The goal of any future revascularization would be to restore direct flow to at least one foot artery, preferably the artery supplying the ulcer region, achieving minimum toe pressure ≥30 mmHg or TcPO₂ ≥25 mmHg. 1
Glycemic Control Optimization
The blood glucose readings show significant variability (150-257 mg/dL), which impairs wound healing and must be tightened.
- Continue the current insulin regimen (Lantus, scheduled NovoLog, sliding scale) but adjust doses to achieve more consistent pre-meal glucose targets of 80-130 mg/dL. 3
- The carbohydrate-consistent diet and AC/HS glucose monitoring should continue. 3
- Tight glycemic control is essential for prevention of foot ulcer progression and promotion of healing, though avoid hypoglycemia given the orthostatic hypotension risk. 4, 5
Oral Candidiasis Management
- The oral candidiasis is reportedly improving with nystatin cream, and the patient denies current oral discomfort. 1
- Continue nystatin if any residual lesions remain visible on examination. 1
- Maintain rigorous oral hygiene and monitor for recurrence, as immunocompromised states from diabetes and poor glycemic control increase fungal infection risk. 1
- If symptoms recur or worsen, consider systemic antifungal therapy rather than topical treatment alone. 1
Infection Surveillance
Given the multiple open wounds and PAD, vigilant infection monitoring is critical:
- Watch specifically for erythema extending >2 cm from wound edges, purulent drainage, warmth, or systemic signs (fever, elevated WBC, elevated CRP) as indicators of infection requiring immediate antibiotic therapy. 1, 3
- Current wound care orders include monitoring for infection signs—this must be performed at every dressing change. 1
- If mild infection develops, start empiric oral antibiotics targeting Staphylococcus aureus and streptococci; if moderate-to-severe infection occurs, initiate broad-spectrum IV antibiotics and consider surgical debridement. 3
- The combination of PAD and infection dramatically increases amputation risk and requires emergency intervention. 1
Cardiovascular Risk Reduction
This patient requires aggressive cardiovascular risk management given the PAD and diabetic foot ulcers:
- Ensure the patient is on a statin (ezetimibe alone is insufficient for this high-risk patient). 1
- Continue aspirin 81 mg daily as currently prescribed. 1
- Support smoking cessation if applicable and treat hypertension aggressively (current BP 126-142 systolic is acceptable). 1
- The cilostazol for PAD is appropriate and should continue. 1
Rehabilitation and Fall Prevention
- Continue PT/OT/ST with noted gradual improvement in post-stroke debility. 1
- Maintain strict fall precautions and supervised transfers given the combination of right-sided weakness, gait instability, neuropathy, and orthostatic hypotension. 3
- The fludrocortisone, PRN midodrine, abdominal binder, and TED hose regimen for orthostatic hypotension should continue. 1
Discharge Planning Considerations
With discharge planned and home health services arranged:
- Ensure detailed wound care instructions are provided, including specific offloading requirements and signs of infection requiring immediate medical attention. 1, 3
- Schedule follow-up within 1-3 months given IWGDF risk category 3 (peripheral neuropathy with history of foot ulcers). 3
- Verify home health can provide appropriate wound care frequency and that durable medical equipment (offloading devices, pressure-relief cushions) will be available at home. 1
- Complete medication reconciliation ensuring all cardiovascular protective medications are included. 1
Critical Pitfalls to Avoid
- Do not allow the patient to walk without proper offloading devices—continued ambulation on ulcerated feet is the primary cause of non-healing. 1
- Do not delay vascular imaging if ulcers fail to improve after 6 weeks—early revascularization improves limb salvage rates. 1
- Do not miss early signs of infection in the setting of PAD—this combination requires emergency treatment to prevent amputation. 1
- Do not accept the current glycemic variability—tighter control is needed for wound healing while avoiding hypoglycemia. 4